| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12084-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75193-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-09026-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35255-10ug | |||
| Carrier-Free | NBP2-35255-1mg | |||
| Carrier-Free | NBP2-35255-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34861-10ug | |||
| Carrier-Free | NBP2-34861-1mg | |||
| Carrier-Free | NBP2-34861-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35032-10ug | |||
| Carrier-Free | NBP2-35032-1mg | |||
| Carrier-Free | NBP2-35032-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35029-10ug | |||
| Carrier-Free | NBP2-35029-1mg | |||
| Carrier-Free | NBP2-35029-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34911-1mg | |||
| Carrier-Free | NBP2-34911-100ug | |||
| Carrier-Free | NBP2-34911-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35122-10ug | |||
| Carrier-Free | NBP2-35122-1mg | |||
| Carrier-Free | NBP2-35122-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35015-10ug | |||
| Carrier-Free | NBP2-35015-1mg | |||
| Carrier-Free | NBP2-35015-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35247-10ug | |||
| Carrier-Free | NBP2-35247-1mg | |||
| Carrier-Free | NBP2-35247-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35301-10ug | |||
| Carrier-Free | NBP2-35301-1mg | |||
| Carrier-Free | NBP2-35301-500ug | |||
![Immunofluorescence: IL6R Antibody (rhPM-1 (Tocilizumab)) - Chimeric [NBP2-75193] - Immunofluorescence staining of fixed U937 cells with anti-IL-6 receptorantibody rhPM-1 (Tocilizumab). Immunofluorescence analysis of paraformaldehyde fixed U937 cells on coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of rhPM-1 (Tocilizumab) (NBP2-75193) at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-75193, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/IL6R-Antibody-rhPM-1-Tocilizumab-Chimeric-Immunofluorescence-NBP2-75193-img0001.jpg "Immunofluorescence: IL6R Antibody (rhPM-1 (Tocilizumab)) - Chimeric [NBP2-75193] - Immunofluorescence staining of fixed U937 cells with anti-IL-6 receptorantibody rhPM-1 (Tocilizumab). Immunofluorescence analysis of paraformaldehyde fixed U937 cells on coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of rhPM-1 (Tocilizumab) (NBP2-75193) at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-75193, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.")
![SDS-Page: Rat IL-7 Protein [NBP2-35255]](http://images.novusbio.com/fullsize/Rat-IL-7-Protein-SDS-Page-NBP2-35255-img0001.jpg "SDS-Page: Rat IL-7 Protein [NBP2-35255]")
![SDS-Page: Recombinant Human IL-22 Protein [NBP2-34861]](http://images.novusbio.com/fullsize/Recombinant-Human-IL-22-Protein-SDS-Page-NBP2-34861-img0002.jpg "SDS-Page: Recombinant Human IL-22 Protein [NBP2-34861]")
![SDS-Page: Human IL-16 130 a.a Protein [NBP2-35032]](http://images.novusbio.com/fullsize/Human-IL-16-130-a.a-Protein-SDS-Page-NBP2-35032-img0001.jpg "SDS-Page: Human IL-16 130 a.a Protein [NBP2-35032]")
![SDS-Page: Human IL-16 121 a.a Protein [NBP2-35029]](http://images.novusbio.com/fullsize/Human-IL-16-121-a.a-Protein-SDS-Page-NBP2-35029-img0001.jpg "SDS-Page: Human IL-16 121 a.a Protein [NBP2-35029]")
![SDS-Page: Human CXCL10/IP-10/CRG-2 Protein [NBP2-34911]](http://images.novusbio.com/fullsize/Human-CXCL10-IP-10-CRG-2-Protein-SDS-Page-NBP2-34911-img0001.jpg "SDS-Page: Human CXCL10/IP-10/CRG-2 Protein [NBP2-34911]")
![SDS-Page: Mouse IL-22 Protein [NBP2-35122]](http://images.novusbio.com/fullsize/Mouse-IL-22-Protein-SDS-Page-NBP2-35122-img0001.jpg "SDS-Page: Mouse IL-22 Protein [NBP2-35122]")
![SDS-Page: Human IL-10 Protein [NBP2-35015]](http://images.novusbio.com/fullsize/Human-IL-10-Protein-SDS-Page-NBP2-35015-img0001.jpg "SDS-Page: Human IL-10 Protein [NBP2-35015]")
![SDS-Page: Rat IL-22 Protein [NBP2-35247]](http://images.novusbio.com/fullsize/Rat-IL-22-Protein-SDS-Page-NBP2-35247-img0001.jpg "SDS-Page: Rat IL-22 Protein [NBP2-35247]")
![SDS-Page: Primate IL-13 Protein [NBP2-35301]](http://images.novusbio.com/fullsize/Primate-IL-13-Protein-SDS-Page-NBP2-35301-img0001.jpg "SDS-Page: Primate IL-13 Protein [NBP2-35301]")